Production & Manufacturing

The National Health Commission and China's National Healthcare Security Administration (NHSA) together unveiled a comprehensive new policy on June 30 called "Several Measures to Support the High-Quality Development of Innovative Drugs". The policy, which was formally unveiled to the...

The pharmaceutical sector stands at the crossroads of innovation and is indeed driven by global healthcare demands, advancements within technology, and immediate calls for sustainable practices. Outsourced pharmaceutical manufacturing, which is led by contract development and manufacturing organizations (CDMOs),...

It is well to be noted that the pharmaceutical sector has for long been characterized by its intricate, global supply chains designed in order to optimize production, decrease costs, and make sure that there is a timely delivery of...

In the very rapidly evolving pharmaceutical spectrum, the safeguarding of injectable biologics happens to be of utmost significance. These delicate products often need strict controls as well as protection from environmental factors that could compromise their efficacy. In the...

A New Era of Biopharma Production with AI The biopharma industry is undergoing a transformation as it capitalises on the potential of artificial intelligence (AI) to revolutionise production processes.  Manufacturers are currently facing the most significant challenge in history: the...

The biopharmaceutical industry in the Asia-Pacific area has seen a significant strategic shift in recent years; this trend is now commonly acknowledged as Asia's bio sovereignty movement. Countries like China, India, Japan, South Korea, and Singapore are making daring...

The Asia-Pacific (APAC) region is fast embracing biomanufacturing, leading-edge technology that is poised to redefine manufacturing processes and efficiency. One of the most revolutionary of these technologies is bringing digital twin technology into play. With the industry facing elevated...